Correlation Between Nkarta and ZyVersa Therapeutics

Can any of the company-specific risk be diversified away by investing in both Nkarta and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nkarta and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nkarta Inc and ZyVersa Therapeutics, you can compare the effects of market volatilities on Nkarta and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nkarta with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nkarta and ZyVersa Therapeutics.

Diversification Opportunities for Nkarta and ZyVersa Therapeutics

0.82

Correlation Coefficient

Nkarta  ZyVersa Therapeutics

Very poor diversification

The 3 months correlation between Nkarta and ZyVersa is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Nkarta Inc and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Nkarta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nkarta Inc are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Nkarta i.e., Nkarta and ZyVersa Therapeutics go up and down completely randomly.

Pair Corralation between Nkarta and ZyVersa Therapeutics

Given the investment horizon of 90 days Nkarta Inc is expected to under-perform the ZyVersa Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Nkarta Inc is 1.72 times less risky than ZyVersa Therapeutics. The stock trades about -0.24 of its potential returns per unit of risk. The ZyVersa Therapeutics is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest  223.00  in ZyVersa Therapeutics on September 12, 2024 and sell it today you would lose (111.00) from holding ZyVersa Therapeutics or give up 49.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Nkarta Inc  vs.  ZyVersa Therapeutics

Nkarta Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nkarta Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

ZyVersa Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Nkarta and ZyVersa Therapeutics

The main advantage of trading using opposite Nkarta and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nkarta position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.

The idea behind Nkarta Inc and ZyVersa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.